Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Elekta AB ( ($SE:EKTA.B) ) is now available.
Elekta has appointed Jakob Just-Bomholt as its new President and CEO, effective September 1, 2025. With a strong background in international leadership and innovation, Just-Bomholt is expected to drive Elekta’s growth and global expansion, enhancing its market position and delivering value to stakeholders, including shareholders, customers, and cancer patients worldwide.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK71.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a leader in precision radiation therapy, dedicated to providing the best cancer care through sustainable, outcome-driven, and cost-efficient solutions. With a global team of 4,500 employees, Elekta focuses on advancing cancer treatment technology and is headquartered in Stockholm, Sweden, with offices in over 40 countries.
YTD Price Performance: -16.61%
Average Trading Volume: 1,326,919
Current Market Cap: SEK19.09B
Learn more about EKTA.B stock on TipRanks’ Stock Analysis page.